Header
Header
Article

New patent for Bioxcel drug IGALMI – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published at New patent for Bioxcel drug IGALMI


Annual Drug Patent Expirations for IGALMI

Igalmi is a drug marketed by Bioxcel and is included in one NDA. There is one patent protecting this drug.

This drug has twenty patent family members in twelve countries.

The generic ingredient in IGALMI is dexmedetomidine hydrochloride. Additional details are available on the dexmedetomidine hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Bioxcel drug IGALMI



Source link

Back to top button